Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19669135 | 0.81 | CES2 (0.36) | CES2 | |
| SCHEMBL24401387 | 0.79 | MEN1 (0.37) | MEN1KMT2A | |
| SCHEMBL24211117 | 0.78 | KDM4E (0.39) | CES2MEN1KMT2A | |
| SCHEMBL21089631 | 0.77 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL12392863 | 0.77 | CES2 (0.38) | CES2 | |
| SCHEMBL19369750 | 0.76 | CES2 (0.37) | CES2 | |
| SCHEMBL19669153 | 0.76 | CES2 (0.37) | CES2 | |
| SCHEMBL22441130 | 0.75 | CES2 (0.33) | CES2 | |
| SCHEMBL24894989 | 0.74 | MEN1 (0.36) | CES2MEN1KMT2A | |
| SCHEMBL20573921 | 0.74 | APLNR (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11529394-B2 | Polypeptide conjugates and methods of uses | BEIJING QL BIOPHARMACEUTICAL CO., LTD. (CN) | 2022-12-20 | — | — | US | disclosed |
| US-20220133856-A1 | POLYPEPTIDE CONJUGATES AND METHODS OF USES | BEIJING QL BIOPHARMACEUTICAL CO., LTD. (CN) | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11529394-B2 | Polypeptide conjugates and methods of uses | GLP1R, GIPR, IAPP | CES2 1562/4885MEN1 1022/4885KMT2A 4037/4885 |
| US-20220133856-A1 | POLYPEPTIDE CONJUGATES AND METHODS OF USES | GLP1R, GIPR, IAPP | CES2 1562/4885MEN1 1022/4885KMT2A 4037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.